Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL)()

Although recent progress in understanding the biology and optimizing the treatment of acute lymphoblastic leukemia (ALL) has improved cure rates of childhood ALL to nearly 90%, the cure rate in adult ALL remains less than 50%. The poor prognosis in adult ALL has in part been attributed to larger pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Oncol
Main Authors: Mutonga, Martin, Tamura, Kenji, Malnassy, Gregory, Fulton, Noreen, de Albuquerque, Amanda, Hamamoto, Ryuji, Stock, Wendy, Nakamura, Yusuke, Alachkar, Houda
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4631083/
https://ncbi.nlm.nih.gov/pubmed/26500027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2015.07.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados